Scarica l'app Stockscreener
0.6385
6.92%
-0.0475
Dopo l'orario di chiusura:
.63
-0.0085
-1.33%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.686
Aprire:
$0.666
Volume 24 ore:
1.29M
Relative Volume:
0.41
Capitalizzazione di mercato:
$26.46M
Reddito:
$1.50M
Utile/perdita netta:
$-64.59M
Rapporto P/E:
-0.3823
EPS:
-1.67
Flusso di cassa netto:
$-55.17M
1 W Prestazione:
+19.68%
1M Prestazione:
+125.62%
6M Prestazione:
+102.06%
1 anno Prestazione:
-72.60%
Intervallo 1D:
$0.6201
$0.709
Intervallo di 1 settimana:
$0.6134
$0.9838
Portata 52W:
$0.2223
$4.79
Leap Therapeutics Inc Stock (LPTX) Company Profile
Nome
Leap Therapeutics Inc
Settore
Industria
Telefono
617 252 4343
Indirizzo
47 THORNDIKE STREET, CAMBRIDGE, MA
Confronta LPTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LPTX
Leap Therapeutics Inc
|
0.6385 | 28.43M | 1.50M | -64.59M | -55.17M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Leap Therapeutics Inc Stock (LPTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-01-29 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2021-10-04 | Iniziato | Mizuho | Buy |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2020-06-29 | Iniziato | Piper Sandler | Overweight |
| 2020-02-11 | Iniziato | Robert W. Baird | Outperform |
| 2019-11-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-09-13 | Ripresa | Raymond James | Outperform |
| 2017-03-07 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Leap Therapeutics Inc Borsa (LPTX) Ultime notizie
Developing predictive dashboards with Leap Therapeutics Inc. dataWeekly Trade Summary & Daily Chart Pattern Signals - newser.com
Institutional scanner results for Leap Therapeutics Inc.July 2025 Price Swings & Reliable Breakout Forecasts - newser.com
Will Leap Therapeutics Inc. stock maintain momentum in 2025July 2025 News Drivers & Entry and Exit Point Strategies - newser.com
Will Leap Therapeutics Inc. (5MC) stock sustain uptrend momentumEarnings Summary Report & Community Trade Idea Sharing - newser.com
Leap Therapeutics Closes $58.88 Million Private Placement In Cash Led by Winklevoss Capital - citybiz
Leap Therapeutics raises $58.9 million for digital asset strategy By Investing.com - Investing.com Canada
Is Leap Therapeutics Inc. (5MC) stock vulnerable to rate hikesWeekly Volume Report & Capital Protection Trade Alerts - newser.com
Leap Therapeutics closes $58.9 million funding led by Winklevoss Capital - Investing.com Canada
How cyclical is Leap Therapeutics Inc. (5MC) stock compared to rivals2025 Historical Comparison & AI Enhanced Trading Signals - newser.com
$58.9M Raise: Leap Therapeutics and Winklevoss Capital to Build Digital Asset Treasury; Board Expanded - Stock Titan
Is Leap Therapeutics Inc. meeting your algorithmic filter criteriaGap Up & Low Risk Entry Point Guides - newser.com
Will Leap Therapeutics Inc. (5MC) stock profit from fiscal stimulusPortfolio Return Report & Stepwise Swing Trade Plans - newser.com
How interest rate cuts could boost Leap Therapeutics Inc. stockJuly 2025 Momentum & Free High Return Stock Watch Alerts - newser.com
Leap Therapeutics secures $58.9M PIPE to launch digital asset strategy; shares up 29% - MSN
Leap Therapeutics Granted Extension by Nasdaq - MSN
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion - MarketScreener
Why Is Leap Therapeutics Down 9% In Pre-Market Trading? - Benzinga
Leap Therapeutics: Blending Biotech and Blockchain - OneSafe
Leap Therapeutics (LPTX) Stock: Soars 58% After $58.9M PIPE Deal with Winklevoss Capital to Launch Crypto Treasury - CoinCentral
Winklevoss-Backed Leap Therapeutics to Start Crypto Treasury - The Crypto Times
Leap Therapeutics (LPTX) Stock Jumps on $58M Winklevoss-Led Crypto Deal - parameter.io
Leap Therapeutics Announces $58.88M Private Placement Led by Winklevoss Capital - citybiz
Leap Therapeutics stock soars after securing $58.9M investment By Investing.com - Investing.com
Biotech Goes Bitcoin: Leap Therapeutics Surges 29% on Groundbreaking Crypto Treasury Deal with Winklevoss Capital - FinancialContent
Leap Therapeutics Shares Jump on $59M Winklevoss-Led Crypto Deal - CoinDesk
Leap Therapeutics (LPTX) Secures $58.9M Financing for Growth Ini - GuruFocus
Leap Therapeutics (LPTX) Announces Strategic Investment and Boar - GuruFocus
Leap therapeutics secures $58.9 million for digital asset strategy By Investing.com - Investing.com Canada
Leap Therapeutics raises $58.9M in private placement for digital assets - Investing.com Canada
Leap Therapeutics Surges on Winklevoss-Led Cash Boost for Crypto Treasury Gamble - RagingBull
$58.9M Raise: Leap Therapeutics Starts Digital Asset Treasury; Winklevoss to Nominate Two Board Members - Stock Titan
Can volume confirm reversal in Leap Therapeutics Inc.2025 Price Action Summary & Safe Entry Zone Tips - newser.com
Reversal indicators forming on Leap Therapeutics Inc. stock2025 Breakouts & Breakdowns & Technical Pattern Based Signals - newser.com
Published on: 2025-10-06 03:41:46 - newser.com
Will Leap Therapeutics Inc. (5MC) stock remain on Wall Street radarWall Street Watch & Reliable Intraday Trade Alerts - newser.com
Heatmap analysis for Leap Therapeutics Inc. and competitorsTake Profit & Verified Momentum Stock Ideas - newser.com
Is Leap Therapeutics Inc. (5MC) stock cheap vs fundamentalsPortfolio Profit Report & Free Community Consensus Stock Picks - newser.com
Published on: 2025-10-05 02:35:13 - newser.com
Leap Therapeutics (LPTX) Plummets Over 20% Amidst Profit-Taking and Volatility Ahead of Key Clinical Data - FinancialContent
What consensus target says about Leap Therapeutics Inc. (5MC) stockWeekly Trade Analysis & Consistent Profit Trade Alerts - newser.com
Is now a turning point for Leap Therapeutics Inc.Weekly Volume Report & Growth Focused Investment Plans - newser.com
Multi asset correlation models including Leap Therapeutics Inc.Profit Target & Daily Oversold Stock Bounce Ideas - newser.com
Candlestick signals on Leap Therapeutics Inc. stock todayJuly 2025 Outlook & Free Safe Capital Growth Stock Tips - newser.com
Is Leap Therapeutics Inc. reversing from oversold territoryMarket Sentiment Review & Safe Capital Allocation Plans - newser.com
Published on: 2025-10-02 20:30:02 - newser.com
Leap Therapeutics Inc Azioni (LPTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):